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Although sleep disorders such as insomnia and obstructive sleep apnea are common in both children and adults,
the clinical features and treatments for these conditions differ considerably between these two populations. Whereas
an adult with obstructive sleep apnea typically presents with a history of obesity, snoring, and prominent daytime
somnolence, a child with the condition is more likely to present with normal body weight, tonsillar hypertrophy,
and inattentiveness during school classes. The adult with suspected sleep apnea almost always undergoes a baseline
polysomnogram and proceeds to treatment only if this test confirms the diagnosis, while many children with
suspected sleep apnea are treated empirically with adenotonsillectomy without ever receiving a sleep study to verify
the diagnosis. This article reviews sleep disorders in children, with a particular focus on age-related changes in
sleep, conditions that primarily affect children, and disorders for which clinical manifestations and treatment differ
substantially from the adult population.
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Evolution of normal sleep during infancy
and early childhood
Healthy term infants spend in excess of 15 h asleep
each day in the form of brief 2–4 h sleep periods.
Periods of sleep and wakefulness are initially dis-
tributed equally across daytime and nighttime hours
with little day-to-day consistency. Longer periods
of wakefulness develop by 6 weeks of age, and by
the age of 3 months, these periods are predictably
distributed during the daytime or early evening
hours.1 As circadian regulatory mechanisms be-
come stronger and entrained by recurring environ-
mental and social cues, sleep lengthens and consoli-
dates during nighttime hours in a process known as
settling . Although 70% of infants settle by 3 months
of age, 10% do not achieve sustained nighttime sleep
during the first year of life.2
The toddler and preschool years are characterized
by additional declines in daily sleep duration from
an average of 13.9 h at 1 year of age to 11.4 h at
age 5.3 Daytime napping begins to subside during
the second year of life, with most children giving up
regular naps around age 3.
The quantitative changes of sleep during early
childhood are accompaniment by significant qual-
itative changes in sleep architecture, which are
demonstrable on electroencephalography (EEG)
and polysomnography (PSG). Rapid eye movement
(REM) sleep constitutes 50% of total sleep time
during early infancy, declining by age 5 to 20%,
the proportion exhibited by older children and
adults.4 Ultradian sleep cycles of REM and non-
REM sleep states are substantially shorter for infants
(50–60 min) than for adults (90–100 min).
Night waking and insomnia in younger
children
It is important to recognize that some degree of
nighttime waking is normal in young children, par-
ticularly during early infancy, when circadian mech-
anisms are still immature and nighttime feedings
a necessity for most infants until about 6 months
of age.5 Among a cohort of children aged 11 to
27 months with no reported sleep problems, acti-
graphic monitoring of nighttime sleep revealed
an average of two awakenings per night.6 Night
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waking is considered problematic when it is ex-
cessively prolonged or frequent for age, or when
it is excessively disruptive to other members of the
household. Overall, about 20% of children below
age 2 years exhibit night waking considered con-
cerning by parents.7
A variety of predisposing influences may be as-
sociated with problematic night waking, some of
which relate to expected developmental changes
during early childhood. Nighttime feeding repre-
sents a biological need for younger infants until
6 months of age, which may persist as a learned be-
havior beyond that time. Near 1 year of age, separa-
tion anxiety may disrupt previously well-established
sleep schedules and result in significant distress dur-
ing episodes of night waking. Cosleeping with a par-
ent is also associated with increased risk for arousal
and awakening during nighttime sleep.8
Insomnia in younger children usually takes the
form of bedtime resistance, in which a child may
cry, repeatedly attempt to leave the room, or en-
gage in other behaviors intended to forestall sleep
onset. These behaviors often result in considerable
distress and frustration for both child and parent.
Although bedtime struggles are at least occasion-
ally observed in most younger children, frequent or
sustained bedtime resistance is exhibited by 20% of
children between 1 and 3 years of age, and by 10%
of 4-year-olds.9
Several factors exhibit strong influences upon set-
tling problems at bedtime. Children whose temper-
amental characteristics are not conducive to self-
settling are at increased risk for bedtime struggles.
Children who lack structured bedtime routines or
have irregular sleep habits represent another high-
risk population. Other extrinsic influences that may
impede settling at bedtime include anxiety, acute
illness, medication side effects, and coexisting med-
ical conditions such as attention deficit hyperactivity
disorder, cerebral palsy, autism, and other develop-
mental disabilities.10
Many young children exhibiting habitual bedtime
struggles or night waking for at least 3 months dura-
tion meet diagnostic criteria for behavioral insom-
nia of childhood (Table 1).11 The essential feature of
this condition is that the difficulty falling asleep or
staying asleep is related to an identified behavioral
etiology—either inappropriate sleep onset associa-
tions or inadequate limit setting. In the sleep-onset
association type, a young child habitually settles to
sleep under circumstances such as being rocked,
watching television, or having a parent present. Af-
fected children become so reliant upon these ha-
bitual sleep associations that they are unable to fall
asleep in their absence. Absence of the desired cir-
cumstances then results in emotional distress, which
can disrupt sleep onset both at bedtime and fol-
lowing the physiological awakenings that punctuate
normal childhood sleep.
The limit-setting type of behavioral insomnia of
childhood occurs when parental or caregiver re-
sponse to bedtime resistance or night waking is
Table 1. Diagnostic criteria for behavioral insomnia of childhood
1. Symptoms must meet criteria for insomnia based on parent or caregiver report
2. The child’s symptoms are consistent with either the sleep-onset association or limit-setting types of insomnia
defined below:
a. Sleep-onset association type includes each of the following:
i. Falling asleep is a protracted process requiring special conditions.
ii. Sleep-onset associations are highly demanding or problematic.
iii. In the absence of the typical associated conditions, sleep onset is substantially delayed or disrupted.
iv. Nighttime awakenings require intervention by the parent or caregiver for the child to return to sleep.
b. Limit-setting type includes each of the following:
i. The child has difficulty initiating or maintaining sleep.
ii. The child stalls or refuses to go to bed at an appropriate time or refuses to return to bed following nighttime
waking.
iii. The parent or caregiver demonstrates inappropriate or insufficient limit setting relative to the child’s bedtime
or sleep behavior.
3. The sleep disturbance is not better explained by another sleep, medical, neurological, or behavioral disorder.
Adapted from the International Classification of Sleep Disorders, second edition.11
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either suboptimal or inconsistent. Whereas firm,
consistent limit setting by parents in response to
bedtime struggles ultimately reduces the duration
and severity of the episodes, inappropriate or in-
consistent caregiver response to the child’s behavior
tends to perpetuate or worsen the problem.
Treatment of sleeplessness during early
childhood
Treatment for milder forms of sleeplessness in in-
fants and young children begins with establishing
good “sleep hygiene.” Use of a structured, age-
appropriate bedtime routine helps younger children
settle into a quiet but relaxed state conducive to sleep
onset. Routines for younger children may include
bathing, changing, tooth brushing, reading stories,
and being “tucked in.” Potentially stimulating activ-
ities such as watching television and vigorous play
should be avoided during the lead-in to bedtime.
Establishing a regular sleep schedule and an ap-
propriate sleep environment are additional impor-
tant elements of sleep hygiene for younger children.
Maintaining regular bedtime and waking times
7 days per week may strengthen and entrain cir-
cadian mechanisms to promote rapid sleep onset
near the desired bedtime. Eliminating daytime sleep
except for age-appropriate naps may also augment
sleepiness at bedtime. The optimal sleep environ-
ment for most young children is one that is quiet
and kept at a stable, comfortable temperature. Al-
though dark sleep environments are most conducive
to sleep, use of dim night lights is appropriate for
young children who are fearful of the dark.
Treatments for behavioral insomnia of and other
persistent forms of sleeplessness during early child-
hood consist primarily of structured behavioral in-
terventions.12 Interventions considered to be well
established for use in younger children include:
Extinction (systematic ignoring). This technique
involves placing the child in bed and then ignoring
any agitation or inappropriate behaviors that the
child exhibits until morning with the exception of
legitimate concerns regarding safety or illness.
Graduated extinction. This technique, described
by Douglas and Richman13 and popularized by Fer-
ber,14 specifies schedules by which parents ignore
tantrums or inappropriate behavior for gradually
increasing intervals before briefly checking on and
reassuring the child.
Positive routines/faded bedtime with response cost .
This technique couples a quiet but enjoyable bed-
time routine with fading of bedtime toward the
child’s time of habitual sleep onset. Response cost
involves taking the child briefly out of bed if not
falling asleep, an application of stimulus control.
Parent education and anticipatory guidance. This
technique, usually coupled with other specific be-
havioral interventions, educates parents and care-
givers about early childhood sleep and the treatable
influences that may promote or disrupt it.
A systematic review15 and practice parameters16
regarding behavioral treatments of sleep problems
in infants and young children reported that sev-
eral varieties of extinction-based therapies, positive
routines with bedtime fading, and parent education
were all individually effective therapies but found
that there was insufficient evidence to recommend
one therapy over another.
Drug treatment of sleeplessness in infants and
young children has received remarkably little sci-
entific study despite reportedly frequent use of
such agents in this age group.17 Controlled trials of
trimeprazine tartrate, a sedating antihistamine, for
treatment of night waking in young children have
yielded conflicting results.18,19 Although melatonin,
diphenhydramine, and chloral hydrate are been
used for treatment of sleep problems in younger
children, reports of efficacy are largely anecdo-
tal apart from a single placebo-controlled trial of
diphenhydramine in infants which did not iden-
tify significant short-term benefits for treatment of
night waking.20,21
Evolution of normal sleep during later
childhood and adolescence
The sleep of school-age and adolescent children
evolves at a more modest pace than that of younger
children. Average daily sleep duration declines from
11 h at 6 years of age to 10 h at age 9, 9 h at age 13,
and 8 h at age 16.3 Maturation of sleep architecture
is characterized by gradual reductions in the pro-
portion of deep non-REM sleep and compensatory
increases in the proportion of light non-REM sleep
stages.
Normal sleep in preadolescent children is accom-
panied by high degrees of baseline alertness during
daytime as measured by the multiple sleep latency
test (MSLT). Mean sleep latency for healthy children
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on the MSLT averages 19 ± 1.6 min, considerably
higher than the 10–13 min range considered nor-
mal for adults.22 Given this high level of baseline
alertness, prominent sleepiness in a preadolescent
child is seldom encountered except in the context
of a severe underlying sleep disorder or significant
sleep deprivation.
During adolescence, daytime sleepiness as mea-
sured by the MSLT increases, which may reflect
the effects of average sleep duration being insuf-
ficient relative to overall sleep needs. 23 In addition,
many healthy adolescents demonstrate tendencies
toward delayed circadian phase, trending toward
progressively later bedtimes and—particularly on
nonschool days—waking times.
Insomnia in older children and adolescents
Insomnia, daytime sleepiness, and other subjec-
tively reported sleep problems remain common for
school-aged children and adolescents, affecting 10–
30% of elementary schoolchildren and a similar
proportion of adolescents.24–26 Social, environmen-
tal, and developmental influences have significant
impact on sleep for this age group. For example,
older children and adolescents gain increasing au-
tonomy regarding their bedtime and sleep schedule
compared with younger children, often resulting
in irregular sleep habits and chronically insuffi-
cient sleep. The widespread availability of televi-
sions, music players, and computers in the bed-
rooms of school-age children and the frequent use
of these devices during nighttime hours is asso-
ciated with increased risk for a variety of sleep
disturbances.27,28 Use of mobile telephones after
bedtime is prevalent among secondary schoolchil-
dren and associated with increased risk for daytime
sleepiness.29
Another strong influence on the sleep patterns
of older school-age children is the well-recognized
tendency toward delayed circadian sleep phase that
develops near adolescence.26 Circadian rhythm dis-
order, delayed sleep phase type, formerly called de-
layed sleep phase syndrome, may be diagnosed when
this tendency results in chronic or recurrent inability
of the child to fall asleep and wake up at conventional
and socially acceptable times.11 When this condition
results in chronically insufficient sleep, it is often ac-
companied by daytime napping, which may make it
more difficult for the child to fall asleep at the desired
bedtime. Habitually later bedtime and waking time
on nonschool nights—common in adolescents—
tend to perpetuate or worsen the tendency toward
delayed sleep phase.30 Delayed sleep phase can be
mimicked or exacerbated when medication or caf-
feine use result in insomnia with chronic sleep de-
privation or when homework or other late-evening
activities habitually delay sleep onset.
Psychophysiological insomnia in older children
is characterized by chronic preoccupation with and
excessive anxiety regarding sleep, which results in
heightened arousal that delays sleep onset.11 Af-
fected children often report anxiety or identifiable
rumination in conjunction with insomnia when try-
ing to fall asleep at bedtime but are sometimes able
to fall asleep easily during sedentary activities or
when away from home.
Treatment of insomnia in older children
and adolescents
Treatment of insomnia during later childhood is
seldom effective unless all pertinent contributory
influences are identified and addressed in the treat-
ment plan. For adolescents in particular, it is com-
mon to identify multiple concurrent influences such
as irregular sleep schedule, excessive caffeine use,
insufficient time allotted for sleep, and tendency to-
ward delayed sleep phase.
Establishing or optimizing appropriate “sleep hy-
giene” is a necessary foundation for other aspects
of treatment. Optimal bedtime and waking time
should be identified based on the child’s age, school
schedule, and individual sleep needs. Because regu-
larity of sleep schedule helps maintain circadian en-
trainment, delayed bedtimes and “sleeping in” on
nonschool days should be avoided whenever pos-
sible. Potentially stimulating activities such as vig-
orous exercise, video gaming, and consumption of
caffeinated beverages should be discouraged during
the evening hours. Eliminating use of electronic de-
vices such as televisions, music players, and portable
telephones in the bedroom near bedtime helps pro-
mote optimal sleep onset associations and a dark,
quiet environment more conducive to sleep initia-
tion and maintenance.
Insomnia related primarily to delayed circa-
dian sleep phase can be treated in several ways.
Mildly delayed sleep phase often responds to con-
sistent enforcement of the desired sleep schedule by
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maintaining target bedtime and waking times 7 days
weekly while eliminating any daytime napping. An
alternative and comparably effective strategy con-
sists of gradually advancing the child’s bedtime and
waking time earlier by 10–15 min each day until the
target schedule is achieved.
More severe or resistant forms of delayed sleep
phase often respond to chronotherapy, a process
by which bedtime and waking time are delayed by
2–3 h nightly until the desired sleep schedule is at-
tained.31 Although this treatment is safe, highly ef-
fective, and does not require use of medication, the
effects of treatment are typically maintained only
if the target sleep schedule is maintained rigorously
7 days weekly following completion of the treatment
protocol. Light therapy, a treatment designed to in-
fluence circadian rhythmicity via structured daily
exposure to high-intensity light, has also been re-
ported to be effective in treating delayed sleep phase
in children and adolescents.32,33
Drug treatment for insomnia in older children
and adolescents has received extremely limited sci-
entific study despite reports that 10–12% of adoles-
cents use medication for treatment of sleep prob-
lems.17,34,35 Melatonin has been reported to be
effective for treatment of insomnia in school-aged
children and adolescents in both uncontrolled36,37
and placebo-controlled38 studies. Although reports
of melatonin treatment for insomnia in children
have assessed doses ranging from 0.3 to 20 mg,39
the side effects, long-term safety, and optimal dos-
ing of this agent for pediatric use have not been well
established.
Numerous other medications are used off label
for the treatment of insomnia in older children in
spite of a paucity of scientific data assessing over-
all safety and efficacy. These include antihistamines,
benzodiazepines, tricyclic agents, alpha-adrenergic
agonists, antipsychotics, herbal preparations, and
newer short-acting hypnotics.17 Pharmacology and
dosing for these agents relative to pediatric sleep
disorders were recently reviewed by Pelayo and
Dubik.21
Non-rapid eyemovement arousal
parasomnias: night terrors and
sleepwalking
Night terrors, sleepwalking, and confusional
arousals in children are thought to represent forms
of incomplete arousal from deep non-REM sleep.
These aberrant arousals are associated with a spec-
trum of behaviors that may range from quiet som-
nambulism to extreme agitation. Episodes occur
most commonly during the early hours of night-
time sleep, when deep non-REM sleep stages are
predominantly distributed, particularly in younger
children. Children are difficult to awaken during
the event, and if awakened, demonstrate little or no
recall for the episode.
Exacerbations of non-REM arousal parasomnias
are often triggered by sleep deprivation or inter-
current illness. Reports of human leukocyte antigen
associations and familial clustering for patients with
arousal parasomnias suggest that these disorders are
subject to strong genetic influences.40,41 Limited ev-
idence suggests that obstructive sleep apnea or rest-
less legs syndrome may represent a treatable precip-
itant of these parasomnias for some children.42
Night terrors and confusional arousals affect up
to 17% of children43 but are most commonly ob-
served in toddlers and preschoolers. The semiology
of events ranges from moaning or quiet crying with
the child remaining in bed to extreme agitation ac-
companied by attempts to flee the room. Episodes
may last as long as 1 hr, but most typically remit
within minutes. Affected children usually have little
or no subsequent recollection of events.
Although 40% of children exhibit at least one
episode of sleepwalking, frequent sleepwalking af-
fects only 2–3%, with peak prevalence near 10 years
of age.43,44 Episodes consist of quiet ambulation last-
ing several minutes, which may include semipur-
poseful activities such wandering to the parent’s
room or urinating in inappropriate locations. Sleep-
walking children seldom sustain serious injury in
their familiar home environment, but risk for in-
jury increases when children leave the house dur-
ing an episode or are sleeping in an unfamiliar
environment.
Treatment of the non-REM arousal parasomnias
in children should commence with the identifica-
tion and treatment of precipitants such as sleep de-
privation or obstructive sleep apnea. It is impor-
tant to safeguard the child’s sleep environment and
limit the child’s access to potentially hazardous ar-
eas inside and outside the house through judicious
use of locks or alarms. Use of scheduled awaken-
ings is often effective for children whose sleepwalk-
ing or night terrors occur at predictable times of
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the night.45,46 Drug treatment using clonazepam
may effective for children having particularly
frequent or severe forms of sleepwalking and night
terrors.47,48
Other childhood parasomnias: nightmares
and enuresis
Nightmares arise from REM sleep and are thought to
result from awakening during a frightening dream.
Agitation following awakening is sometimes con-
siderable, but the fact that the child awakens fully,
responds to consolation by the parent, and has rec-
ollection of dream content helps distinguish night-
mares from night terrors. Nightmares usually arise
during the latter half of the child’s nighttime sleep
period, when REM periods are usually longest and
most prevalent. Nightmares during childhood are
common, affecting over half of early school-aged
children on an occasional basis but only 3% of chil-
dren more than once weekly.49
Occasional nightmares in otherwise healthy chil-
dren represent a self-limited problem that seldom
requires further assessment or treatment. Persistent
nightmares which are unexpectedly frequent, pro-
longed, or violent in content, however, may signal a
need for further investigation of potential medical
and psychological causes.
Sleep enuresis in children is characterized by re-
current involuntary voiding during sleep at a level
that is inappropriate for age, defined by the Inter-
national Classification of Sleep Disorders as more
than twice weekly for children older than 5 years
of age.11 Sleep enuresis is defined as primary if
the child has never remained consistently dry dur-
ing sleep and secondary if the child had previously
been consistently dry for at least 6 months. Noctur-
nal enuresis becomes less common with advancing
age, affecting 15% of 3- to 10-year-olds, but only
2% of 13-year-olds.43 Boys are affected three times
as frequently as girls. Postulated causes of primary
enuresis include immaturity of arousal mechanisms,
reduced functional bladder capacity, and genetic
predisposition.
Treatment of primary sleep enuresis in children
varies depending on age and severity. Most younger
children with primary enuresis outgrow the con-
dition by adolescence without treatment. Children
with frequent or persistent forms of primary enure-
sis often respond to behaviorally based therapies
and conditioning programs that incorporate fluid
restriction, planned awakenings, bladder training
exercises, behavioral incentives, and enuresis alarms
either independently or in combination.50,51 Drug
treatment using desmopressin52 and imipramine53
is also effective for many children with sleep enure-
sis, but reports of hyponatremia54 and other poten-
tially serious mediation-related side effects53 suggest
that these agents are best used within the context of
a comprehensive and closely supervised treatment
program.
Children with secondary sleep enuresis or refrac-
tory primary enuresis sometimes require evaluation
for underlying urological or sleep disorders. Sleep
enuresis is frequently associated with symptoms of
obstructive sleep apnea in children.55,56 In one se-
ries of 144 children with PSG-confirmed obstructive
sleep apnea, 42 (29%) demonstrated sleep enure-
sis prior to treatment.57 Among the 27 children
with enuresis treated with adenotonsillectomy, 11
(41%) experienced resolution of bedwetting within
1 month following surgery.
Sleep-related movement disorders:
restless legs syndrome and rhythmic
movement disorder
Restless legs syndrome (RLS) and periodic limb
movement disorder (PLMD) are distinct but related
conditions only recently recognized in the pediatric
age group. Symptoms of RLS in children include
dysesthesias or urges to move the legs, which are
usually most prominent at night and relieved by
movement.11 Children with growing pains often
meet diagnostic criteria for RLS as well.58 Child-
hood PLMD is characterized by excessive periodic
limb movements occurring over five times per hour
of sleep during PSG, accompanied by clinical com-
plaints of disturbed sleep.11 Although RLS and
PLMD are often comorbid conditions in both chil-
dren and adults, the association is not obligate and
either condition may present independently.
Leg restlessness and growing pains affect up
to 17% and 8% of children, respectively,59 but
only 2% of children meet diagnostic criteria for
clinically definite RLS.60 Multiple studies have re-
ported association between childhood RLS/PLMD
and symptoms of attention deficit hyperactivity dis-
order (ADHD);61–63 however, the strength and clin-
ical significance of this association remains incom-
pletely defined. Several reports suggest that genetic
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Table 2. Diagnostic criteria for pediatric obstructive sleep apnea
1. Parent or caregiver report of snoring or other obstructive symptoms during sleep
2. Parent or caregiver report of at least one associated symptom:
a. Paradoxical chest wall motion during inspiration
b. Movement arousals
c. Excessive perspiration
d. Unusual sleeping positions, for example, neck hyperextension
e. Daytime symptoms: hyperactivity, aggressive behavior, or sleepiness
f. Impaired growth
g. Headache upon waking
h. Secondary enuresis
3. PSG documents at least one scoreable respiratory event per hour of sleep (events lasting at least two respiratory
cycles in duration)
4. PSG demonstrates either a or b:
a. At least one of the following findings:
i. Frequent arousals associated with increased respiratory effort
ii. Desaturation with apneic events
iii. Hypercapnia in sleep
iv. Excessively negative esophageal pressure fluctuations
b. Periods of abnormal gas exchange during sleep (hypoxemia, hypercapnea, or both) with snoring, paradoxical
chest wall motion, and at least one of the following:
i. Frequent arousals during sleep
ii. Excessively negative esophageal pressures swings
5. The disorder is not better explained by other sleep disorders, medical or neurological conditions, or by medication
or substance use
Adapted from the International Classification of Sleep Disorders, second edition.11
influences64 and iron deficiency states65 may play a
causative role in childhood RLS. Treatment options
for childhood RLS/PLMD consist of iron supple-
mentation for children with low ferritin levels or
other evidence of iron deficiency,66,67 or judicious
use of dopaminergic agonists.68,69
Sleep-related rhythmic movement disorder
(RMD) is characterized by recurrent and well-
stereotyped rhythmic behaviors associated with
sleep.11,70 Common behaviors include head bang-
ing (jactatio capitis nocturna), head or body rolling,
and body rocking. Movements typically involve the
large muscle groups of the head, trunk, or limbs
at a frequency of 0.5 to 2 Hz, often accompanied
by synchronous humming or moaning vocaliza-
tions. Episodes of rhythmic movement typically last
for several minutes but may recur throughout the
night. RMD is unique among the parasomnias inso-
far as episodes may commence during wakefulness
but persist during and following transition into sus-
tained sleep.
Sleep-related rhythmic behaviors are observed in
a majority of infants, but these behaviors subside
before 5 years of age in most children.71 By early
adolescence, only 3% of children manifest promi-
nent rhythmic behaviors associated with sleep.43 For
most affected children, RMD is a self-limited con-
dition that does not require treatment. For children
exhibiting particularly prolonged or violent forms of
RMD, treatment options include benzodiazepines,
behavioral therapies, or use of padding and protec-
tive helmets.72
Sleep-disordered breathing in children
The first modern description of obstructive sleep
apnea (OSA) in children was provided by Guillem-
inault and colleagues in 1976.73 This and subse-
quent reports have characterized childhood OSA as
a condition characterized by upper airway obstruc-
tion that disturbs sleep quality, sometimes associ-
ated with recurrent oxyhemoglobin desaturation or
(less commonly) hypercapnia.
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Table 3. Clinical features of obstructive sleep apnea in children compared to adults
Children Adults
Physical characteristics
Gender Younger children: sexes equally affected Primarily males, postmenopausal females
Adolescents: males > females
Peak age 2–8 years Middle age and older
Body weight Usually normal, occasionally overweight Most often obese
Upper airway Adenotonsillar enlargement frequent Adenotonsillar enlargement occasional
Redundant soft tissue occasional Redundant soft tissue frequent
Symptoms during sleep
Snoring Frequent, continuous or intermittent Frequent, often interrupted by pauses
Witnessed apnea Occasional Frequent
PSG characteristics
Obstruction Prolonged partial obstruction > intermittent Cyclical intermittent obstruction
Sleep architecture Normal > fragmented Frequent arousals with sleep fragmentation
Secondary symptoms
Daytime sleepiness Most often absent or intermittent Frequent, usually prominent
Neurobehavioral Inattention, hyperkinesis, disturbed behavior Cognitive slowing, increased accident risk
Cardiovascular Hypertension, cor pulmonale Hypertension, heart disease, stroke
Criteria for the diagnosis of childhood OSA,
summarized in Table 2, were established by the In-
ternational Classification of Sleep Disorders, second
edition.11 This classification, however, did not spec-
ify criteria for other varieties of sleep-disordered
breathing sometimes observed in children. Children
with neuromuscular disorders, underlying lung dis-
ease, or severe varieties of partial airway obstruc-
tion sometimes exhibit sleep-related hypoventila-
tion, characterized by persistent hypercapnia during
sleep.74 Upper airway resistance syndrome (UARS),
a condition in which prolonged partial airway ob-
struction during sleep disturbs sleep quality in the
absence of apnea or desaturation, has also been de-
scribed in children.75
It is estimated that about 2% of children suf-
fer from OSA.76 The condition may develop at any
time during childhood but is most frequent between
2 and 8 years of age, the age range when adenoton-
sillar size is largest relative to size of the airway. OSA
is equally frequent in boys and girls until adoles-
cence, when the condition becomes more common
in males. Other genetic, neurological, and cranio-
facial conditions are associated with increased risk
for the development of childhood OSA, particularly
Down syndrome, in which half of children may be
affected.77,78
The clinical features of OSA in children are dis-
tinct from those of adults, as summarized in Table 3.
Snoring is usually present in affected children, but
frequency and severity are highly variable. Other
common symptoms during nighttime sleep include
mouth breathing, restlessness, diaphoresis, and un-
usual sleeping positions. Symptoms upon waking
may include sore throat, dry mouth, headache, and
transient grogginess. Daytime somnolence is sel-
dom prominent in younger children with OSA un-
less obstruction is particularly severe.
A number of studies suggest that disturbances
of attention, behavior, and academic performance
are commonly associated with childhood OSA and
may improve following treatment. Sleep-disordered
breathing was identified in 18% of 297 first-grade
children with poor academic achievement in one
study.79 Upon reassessment 1 year later, the 24 af-
fected children who had been treated with ade-
notonsillectomy demonstrated significant academic
improvement (P < 0.001) compared with untreated
and unaffected children. In a more recent study
of 78 children undergoing adenotonsillectomy for
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suspected sleep-disordered breathing, 22 (28%) met
DSM-IV criteria for the diagnosis of ADHD preop-
eratively, but only half of these children still met
criteria for the diagnosis of ADHD 1 year following
surgery.80
The long-term effects and clinical sequelae
of childhood OSA remain incompletely under-
stood. Multiple reports suggest associations between
childhood OSA and hypertension.81,82 Reversible
cor pulmonale has also been reported in severely
affected children.83,84
The physical examination of children with OSA
is often normal, but findings such as tonsillar hy-
pertrophy, narrow upper palate, and low-lying soft
palate are frequently identified. Mouth breathing
with elongated facial appearance is sometimes ap-
parent in children with underlying adenoidal hy-
pertrophy. Other occasionally encountered physical
features associated with increased risk for sleep-
related airway obstruction include maxillary or
mandibular hypoplasia, macroglossia, or nasal sep-
tal deviation. Although body weight is normal for
most children with OSA, obesity nevertheless rep-
resents a clearly identifiable risk factor, particularly
in adolescents.85,86
The diagnosis of childhood OSA (Table 2)
is established on the basis of both clinical and
polysomnographic criteria.87 Lab-based PSG is
now widely but not universally available for chil-
dren, but the number of sleep laboratories having
substantial experience in pediatric studies remains
limited. Specific norms for the interpretation of
PSG in children have been established,74,88 which
are distinct from adult norms and reflect the
fact that adult criteria often fail to identify chil-
dren with serious obstruction.89 PSG can be cus-
tomized through addition of end-tidal carbon
dioxide or esophageal pressure monitoring if sleep-
related hypoventilation or upper airway resistance
syndrome are clinically suspected. A variety of
techniques are available for making PSG more
“child friendly.”90
Adenotonsillectomy (AT) is the most common
treatment of childhood OSA. This procedure has
been used for decades to alleviate upper airway
obstruction in children with suspected or docu-
mented OSA.91 Although previously issued prac-
tice guidelines92 and meta-analysis of published
research93 had estimated that the procedure was ef-
fective in curing childhood OSA in over 75% of
cases, these estimates were limited by substantial
variability in the criteria used to define childhood
OSA and measure outcome. Several large, recent
studies using contemporary criteria and PSG tech-
niques to study the efficacy of AT in treating child-
hood OSA reported that complete normalization of
the PSG may occur in only 25%94 to 50%95 of treated
children. These and other data suggest that health-
care practitioners should remain vigilant for resid-
ual or recurrent96,97 OSA in children treated with
AT.
Nasal CPAP (continuous positive airway pres-
sure) is an alternative first-line treatment for OSA
in children of all ages.98 Advantages of CPAP in-
clude the facts that the treatment is nonsurgical,
generally safe, and effective for treatment of sleep-
disordered breathing related to factors independent
from adentonsillar hypertrophy. Limitations of this
treatment include the fact that some children—
especially those who are young or have concurrent
developmental disabilities—may not acclimate eas-
ily to use of the device, although specific desensitiza-
tion techniques are often helpful in these patients.99
Alternative and investigational medical treat-
ments for childhood OSA include use of sup-
plemental oxygen and positional therapy. Use of
nasal steroid preparations may be effective in some
cases;100,101 however, the long-term efficacy and
safety of this treatment in children have not been
established. Surgical treatments sometimes used for
treatment of children with complicated OSA include
uvulopaltopharyngoplasty (UPPP), distraction os-
teogenesis, and mandibular or maxillary advance-
ment procedures. Tracheostomy is used only as a
last resort in children whose OSA is both severe and
refractory to more conventional therapies.
Childhood hypersomnias
Excessive daytime sleepiness in children is most of-
ten secondary to other sleep problems such as in-
sufficient sleep or more severe forms of obstructive
sleep apnea. Nevertheless, primary hypersomnias
such as narcolepsy and Kleine-Levin syndrome are
occasionally observed in children.
As is the case for adults, narcolepsy in chil-
dren is characterized by excessive daytime som-
nolence, which may be accompanied by cataplexy,
sleep paralysis, and hallucinations at sleep onset or
offset. Onset of symptoms most commonly occurs
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during the second decade,102 usually in the form of
isolated sleepiness, which can develop in either an
abrupt or insidiously progressive fashion. Cataplexy,
sleep paralysis, and other associated symptoms of
narcolepsy, when present, may develop months to
years after the child becomes somnolent. Evolution
of severe somnolence or cataplexy at an especially
young age or in an atypical fashion is sometimes
observed in children with other medical conditions
such as Niemann-Pick disease type C103 or Prader-
Willi syndrome.104
The diagnosis of narcolepsy in children is based
on the presence of typical clinical features, supple-
mented by nocturnal PSG—to screen for other sleep
disorders that may cause excessive sleepiness—and
daytime MSLT interpreted using pediatric norms.22
Most children with narcolepsy demonstrated mean
sleep latency of fewer than 7 min and multiple sleep-
onset REM periods on their MSLT studies.105
Treatment of narcolepsy in children parallels that
of adults in most respects. Although detailed prac-
tice parameters106 and guidelines for treatment of
narcolepsy107 have been published, these do not
specifically address drug treatment in children,
which is undertaken on an off-label basis. Daytime
sleepiness in narcoleptic children is treated using
modafinil, stimulants, and other wake-promoting
medications, sometimes supplemented by planned
daytime naps. Cataplexy often responds to adminis-
tration of tricyclic antidepressant agents or selective
serotonin reuptake inhibitors. Sodium oxybate has
been found to be effective in the treatment of sleepi-
ness and cataplexy in adults with narcolepsy, and
limited data suggest that this agent may be effective
for affected children as well.108
Kleine-Levin syndrome, also known as recurrent
hypersomnia, is a rare disorder characterized by re-
current episodes of excessive sleepiness, often ac-
companied by concurrent behavioral disturbances,
which may include irritability, aggression, marked
changes in appetite, and hypersexual behavior.11
Episodes last from several days to several weeks and
occur between once and 10 times yearly. Kleine-
Levin syndrome most commonly affects adolescent
males, and limited evidence suggests that the sever-
ity and duration of the condition may be worse for
patients who are older at the age of onset.109
The pathophysiology of Kleine-Levin syndrome
remains poorly understood, but SPECT studies sug-
gest that intermittent disturbances of hypothalamic,
thalamic, and fronto-temporal function may coin-
cide with episodes.110,111 Treatment of the condi-
tion is symptomatic and often includes mood sta-
bilizers and wake-promoting medications such as
modafinil.
Conflicts of interest
The author declares no conflicts of interest.
References
1. Coons, S., C. Guilleminault, S. Coons & C. Guillem-
inault. 1982. Development of sleep-wake patterns and
non-rapid eye movement sleep stages during the first
six months of life in normal infants. Pediatrics 69: 793–
798.
2. Guilleminault, C. & T.F. Anders. 1976. The pathophys-
iology of sleep disorders in pediatrics. Part II. Sleep
disorders in children. Adv. Pediatrics 22: 151–174.
3. Iglowstein, I., O.G. Jenni, L. Molinari & R.H. Largo.
2003. Sleep duration from infancy to adolescence: ref-
erence values and generational trends [see comment].
Pediatrics 111: 302–307.
4. Anders, T.F. & C. Guilleminault. 1976. The pathophys-
iology of sleep disorders in pediatrics. Part I. Sleep in
infancy. Adv. Pediatrics 22: 137–150.
5. Ferber, R.. 1996. Childhood sleep disorders. Neurol.
Clin. 14: 493–511.
6. Sadeh, A., P. Lavie, A. Scher, et al. 1991. Actigraphic
home monitoring of sleep-disturbed and control in-
fants and young children: a new method for pediatric
assessment of sleep-wake patterns. Pediatrics 87: 494–
499.
7. Sheldon, S.H. 2005. Disorders of initiating and main-
taining sleep. In Principles and Practice of Pediatric Sleep
Medicine. Sheldon, S.H., R. Ferber & M.H. Kryger, Eds.:
127–160. Philadelphia: Saunders.
8. Mosko, S., C. Richard & J. McKenna. 1997. Infant
arousals during mother-infant bed sharing: implica-
tions for infant sleep and sudden infant death syndrome
research. Pediatrics 100: 841–849.
9. Ramchandani, P., L. Wiggs, V. Webb & G. Stores. 2000.
A systematic review of treatments for settling problems
and night waking in young children. BMJ 320: 209–213.
10. Stores, G. 1999. Children’s sleep disorders: modern ap-
proaches, developmental effects, and children at special
risk. Dev. Med. Child Neurol. 41: 568–573.
11. Anonymous. 2005. The International Classification of
Sleep Disorders, 2nd edn. American Academy of Sleep
Medicine. Westchester.
10 Ann. N.Y. Acad. Sci. 1184 (2010) 1–14 c© 2009 New York Academy of Sciences.
Hoban Sleep disorders in children
12. Kuhn, B.R. & A.J. Elliott. 2003. Treatment efficacy in
behavioral pediatric sleep medicine. J. Psychosom. Res.
54: 587–597.
13. Douglas, J & N. Richman. 1984. My Child Won’t Sleep.
Penguin Books. Harmondsworth.
14. Ferber, R. 1985. Solve Your Child’s Sleep Problems. Si-
mon & Schuster. New York.
15. Mindell, J.A., B. Kuhn, D.S. Lewin, et al. 2006. Behav-
ioral treatment of bedtime problems and night wak-
ings in infants and young children [erratum appears in
Sleep. 2006 Nov 1;29(11):1380]. Sleep 29: 1263–1276.
16. Morgenthaler, T.I., J. Owens, C. Alessi, et al. 2006. Prac-
tice parameters for behavioral treatment of bedtime
problems and night wakings in infants and young chil-
dren. Sleep 29: 1277–1281.
17. Owens, J.A., C.L. Rosen & J.A. Mindell. 2003. Medica-
tion use in the treatment of pediatric insomnia: results
of a survey of community-based pediatricians. Pedi-
atrics 111(5 Pt 1): e628–e635.
18. France, K.G., N.M. Blampied & P. Wilkinson. 1999. A
multiple-baseline, double-blind evaluation of the ef-
fects of trimeprazine tartrate on infant sleep distur-
bance. Exp. Clin. Psychopharmacol. 7: 502–513.
19. Simonoff, E.A. & G. Stores. 1987. Controlled trial of
trimeprazine tartrate for night waking. Arch. Dis. Child.
62: 253–257.
20. Merenstein, D., M. Diener-West, A.C. Halbower, et al.
2006. The trial of infant response to diphenhydramine:
the TIRED study–a randomized, controlled, patient-
oriented trial. Arch. Pediatr. Adolesc. Med. 160: 707–
712.
21. Pelayo, R. & M. Dubik. 2008. Pediatric sleep pharma-
cology. Semin. Pediatr. Neurol. 15: 79–90.
22. Hoban, T.F. & R.D. Chervin. 2001. Assessment of sleepi-
ness in children. Semin. Pediatr. Neurol. 8: 216–228.
23. Carskadon, M.A. & W. Dement. 1987. Sleepiness in
the normal adolescent. In Sleep and Its Disorders in
Children. Guilleminault, C. Ed.: 53–66. Raven Press.
New York.
24. Blader, J.C., H.S. Koplewicz, H. Abikoff & C. Foley.
1997. Sleep problems of elementary school children.
Arch. Pediatr. Adolesc. Med. 151: 473–480.
25. Saarenpaa-Heikkila, O., P. Laippala & M. Koivikko.
2000. Subjective daytime sleepiness in schoolchildren.
Family Pract. 17: 129–133.
26. Carskadon, M.A.. 1982. The second decade. In Sleep-
ing and Waking Disorders: Indications and Techniques.
Guilleminault, C. Ed.: 99–125. Addison Wesley. Menlo
Park.
27. Van Den Bulck, J. 2004. Television viewing, computer
game playing, and Internet use and self-reported time
to bed and time out of bed in secondary-school children
[see comment]. Sleep 27: 101–104.
28. Owens, J., R Maxim, M. McGuinn, et al. 1999.
Television-viewing habits and sleep disturbance in
school children. Pediatrics 104: e27.
29. Van Den Bulck, J. 2007. Adolescent use of mobile
phones for calling and for sending text messages af-
ter lights out: results from a prospective cohort study
with a one-year follow-up. Sleep 30: 1220–1223.
30. Crowley, S.J., C. Acebo, M.A. Carskadon, et al. 2007.
Sleep, circadian rhythms, and delayed phase in adoles-
cence. Sleep Med. 8: 602–612.
31. Czeisler, C., G. Richardson, R. Coleman, et al. 1981.
Chronotherapy: resetting the circadian clocks of pa-
tients with delayed sleep phase insomnia. Sleep 4: 1–21.
32. Guilleminault, C., C.C. McCann, M. Quera-Salva & M.
Cetel. 1993. Light therapy as treatment of dyschronosis
in brain impaired children. Eur. J. Pediatr. 152: 754–
759.
33. Okawa, M., M. Uchiyama, S. Ozaki, et al. 1998. Cir-
cadian rhythm sleep disorders in adolescents: clinical
trials of combined treatments based on chronobiology.
Psychiatry Clin. Neurosc. 52: 483–490.
34. Patois, E., J. Valatz & A. Alperovitch. 1993. Prevalence of
sleep and wakefulness disorders in high school students
at the Academy of Lyon. Rev. Epiedmiol. Sante Publique
41: 383–388.
35. Ledoux, S., M. Choquet & R. Manfredi. 1994. Self-
reported use of drugs for sleep or distress among French
adolescents. J. Adolesc. Health 15: 495–502.
36. Ivanenko, A., V.M. Crabtree, R. Tauman & D. Gozal.
2003. Melatonin in children and adolescents with in-
somnia: a retrospective study. Clin. Pediatr. 42: 51–58.
37. Szeinberg, A., K. Borodkin, Y. Dagan, et al. 2006. Mela-
tonin treatment in adolescents with delayed sleep phase
syndrome. Clin. Pediatr. (Phila) 45: 809–818.
38. Smits, M., H. Van Stel, K. Van Der Heijen, et al. 2003.
Melatonin improves health status and sleep in children
with idiopathic chronic sleep-onset insomnia: a ran-
domized, placebo-controlled trial. J. Am. Acad. Child
Adolesc. Psychiatry 42: 1286–1293.
39. Stores, G. 2003. Medication for sleep-wake disorders.
Arch. Dis. Child. 88: 899–903.
40. Hublin, C., J. Kaprio, M. Partinen & M. Koskenvu.
2001. Parasomnias: co-occurrence and genetics. Psy-
chiatr. Genet. 11: 65–70.
41. Lecendreux, M., C. Bassetti, Y. Dauvilliers, et al. 2003.
HLA and genetic susceptibility to sleepwalking. Mol.
Psychiatry 8: 114–117.
Ann. N.Y. Acad. Sci. 1184 (2010) 1–14 c© 2009 New York Academy of Sciences. 11
Sleep disorders in children Hoban
42. Guilleminault, C., L. Palombini, R. Pelayo, et al. 2003.
Sleepwalking and sleep terrors in prepubertal children:
what triggers them? Pediatrics 111: e17–e25.
43. Laberge, L., R.E. Tremblay, F. Vitaro & J. Montplaisir.
2000. Development of parasomnias from childhood to
early adolescence. Pediatrics 106: 67–74.
44. Klackenberg, G. 1982. Somnambulism in childhood–
prevalence, course and behavioral correlations. A
prospective longitudinal study (6–16 years). Acta Pae-
diatrica Scandinavica 71: 495–499.
45. Frank, N.C., A. Spirito, L. Stark & J. Owens-Stively.
1997. The use of scheduled awakenings to eliminate
childhood sleepwalking. J. Pediatr. Psychol. 22: 345–
353.
46. Durand, V.M. & J.A. Mindell. 1999. Intervention for
childhood sleep terrors. Behav. Ther. 30: 705–715.
47. Remulla, A., C. Guilleminault, A. Remulla & C.
Guilleminault. 2004. Somnambulism (sleepwalking).
Expert Opin. Pharmacother. 5: 2069–2074.
48. Pesikoff, R. & P. Davis. 1971. Treatment of pavor noctur-
nus and somnambulism in children. Am. J. Psychiatry
128: 778–781.
49. Smedje, H., J.E. Broman, J. Hetta, et al. 1999. Parents’
reports of disturbed sleep in 5–7-year-old Swedish chil-
dren. Acta Paediatrica 88: 858–865.
50. Butler, R.J., P. Holland, S. Gasson, et al. 2007. Exploring
potential mechanisms in alarm treatment for primary
nocturnal enuresis. Scand. J. Urol. Nephrol. 41: 407–413.
51. Lottmann, H.B. & I. Alova. 2007. Primary monosymp-
tomatic nocturnal enuresis in children and adolescents.
Int. J. Clin. Pract. Supplement(155): 8–16.
52. Ferrara, P., G. Marrone, V. Emmanuele, et al. 2008.
Homotoxicological remedies versus desmopressin ver-
sus placebo in the treatment of enuresis: a randomised,
double-blind, controlled trial [see comment]. Pediatr.
Nephrol. 23: 269–274.
53. Neveus, T., K. Tullus, T. Neveus & K. Tullus. 2008.
Tolterodine and imipramine in refractory enuresis; a
placebo-controlled crossover study. Pediatr. Nephrol.
23: 263–267.
54. Larney, V. & R. Dwyer. 2006. Hyponatraemic convul-
sions and fatal head injury secondary to desmopressin
treatment for enuresis. Eur. J. Anaesthesiol. 23: 895–
897.
55. Stone, J., P.S. Malone, D. Atwill, et al. 2008. Symptoms
of sleep-disordered breathing in children with noctur-
nal enuresis. J. Pediatr. Urol. 4: 197–202.
56. Weider, D.J. & P.J. Hauri. 1985. Nocturnal enuresis in
children with upper airway obstruction. Int. J. Pediatr.
Otorhinolaryngol. 9: 173–182.
57. Weissbach, A., A. Leiberman, A. Tarasiuk, et al. 2006.
Adenotonsilectomy improves enuresis in children with
obstructive sleep apnea syndrome. Int. J. Pediatr.
Otorhinolaryngol. 70: 1351–1356.
58. Rajaram, S.S., A.S. Walters, S.J. England, et al. 2004.
Some children with growing pains may actually have
restless legs syndrome. Sleep 27: 767–773.
59. Chervin, R.D., K.H. Archbold, J.E. Dillon, et al. 2002.
Associations between symptoms of inattention, hyper-
activity, restless legs, and periodic leg movements. Sleep
25: 213–218.
60. Picchietti, D., R.P. Allen, A.S. Walters, et al. 2007. Rest-
less legs syndrome: prevalence and impact in children
and adolescents–the Peds REST study [see comment].
Pediatrics 120: 253–266.
61. Cortese, S., E. Konofal, M. Lecendreux, et al. 2005. Rest-
less legs syndrome and attention-deficit/hyperactivity
disorder: a review of the literature. Sleep 28: 1007–1013.
62. Picchietti, D.L., D.J. Underwood, W.A. Farris, et al.
1999. Further studies on periodic limb movement
disorder and restless legs syndrome in children with
attention-deficit hyperactivity disorder. Mov. Disord.
14: 1000–1007.
63. Picchietti, D.L., S.J. England, A.S. Walters, et al. 1998.
Periodic limb movement disorder and restless legs syn-
drome in children with attention-deficit hyperactivity
disorder. J. Child Neurol. 13: 588–594.
64. Muhle, H., A. Neumann, K. Lohmann-Hedrich, et al.
2008. Childhood-onset restless legs syndrome: clinical
and genetic features of 22 families. Mov. Disord. 23:
1113–1121; quiz 203.
65. Oner, P., E.B. Dirik, Y. Taner, et al. 2007. Association
between low serum ferritin and restless legs syndrome
in patients with attention deficit hyperactivity disorder.
Tohoku J. Exp. Med. 213: 269–276.
66. Picchietti, M.A., D.L. Picchietti, M.A. Picchietti & D.L.
Picchietti. 2008. Restless legs syndrome and periodic
limb movement disorder in children and adolescents.
Semin. Pediatr. Neurol. 15: 91–99.
67. Kryger, M.H., K. Otake & J. Foerster. 2002. Low body
stores of iron and restless legs syndrome: a correctable
cause of insomnia in adolescents and teenagers. Sleep
Med. 3: 127–132.
68. Konofal, E., I. Arnulf, M. Lecendreux, et al. 2005.
Ropinirole in a child with attention-deficit hyperactiv-
ity disorder and restless legs syndrome. Pediatr. Neurol.
32: 350–351.
69. Walters, A.S., D.E. Mandelbaum, D.S. Lewin, et al.
2000. Dopaminergic therapy in children with restless
legs/periodic limb movements in sleep and ADHD.
12 Ann. N.Y. Acad. Sci. 1184 (2010) 1–14 c© 2009 New York Academy of Sciences.
Hoban Sleep disorders in children
Dopaminergic Therapy Study Group. Pediatr. Neurol.
22: 182–186.
70. Hoban, T.F. 2003. Rhythmic movement disorder in chil-
dren. Cns Spectrums 8: 135–138.
71. Klackenberg, G. 1971. Rhythmic movements in in-
fancy and early childhood. Acta Paediatrica Scandinav-
ica 224(suppl): 74–82.
72. Hoban, T.F. Sleep related rhythmic movement disorder.
In The Parasomnias and Other Sleep-related Movement
Disorders. Thorpy, M. & G. Plazzi, Eds. Cambridge Uni-
versity Press. Cambridge. In Press.
73. Guilleminault, C., F.L. Eldridge, F.B. Simmons & W.C.
Dement. 1976. Sleep apnea in eight children. Pediatrics
58: 23–30.
74. Iber, C., S. Ancoli-Israel, A. Chesson & S.F. Quan. 2007.
The AASM Manual for the Scoring of Sleep and Asso-
ciated Events. American Academy of Sleep Medicine.
Westchester.
75. Guilleminault, C., R. Pelayo, D. Leger, et al. 1996.
Recognition of sleep-disordered breathing in children.
Pediatrics 98: 871–882.
76. Marcus, C.L. 2001. Sleep-disordered breathing in chil-
dren. Am. J. Respir. Crit. Care Med. 164: 16–30.
77. Shott, S.R., R. Amin, B. Chini, et al. 2006. Obstructive
sleep apnea: Should all children with Down syndrome
be tested? Arch. Otolaryngol. – Head Neck Surg. 132:
432–436.
78. Ng, D.K., H.N. Hui, C.H. Chan, et al. 2006. Obstructive
sleep apnoea in children with Down syndrome. Singa-
pore Med. J. 47: 774–779.
79. Gozal, D. 1998. Sleep-disordered breathing and school
performance in children. Pediatrics 102: 616–620.
80. Chervin, R.D., D.L. Ruzicka, B.J. Giordani, et al. 2006.
Sleep-disordered breathing, behavior, and cognition in
children before and after adenotonsillectomy. Pediatrics
117: e769–e778.
81. Li, A.M., C.T. Au, R.Y. Sung, et al. 2008. Ambulatory
blood pressure in children with obstructive sleep ap-
noea: a community based study. Thorax 63: 803–809.
82. Leung, L.C., D.K. Ng, M.W. Lau, et al. 2006. Twenty-
four-hour ambulatory BP in snoring children with ob-
structive sleep apnea syndrome. Chest 130: 1009–1017.
83. Cox, M.A., G.L. Schiebler, W.J. Taylor, et al. 1965. Re-
versible pulmonary hypertension in a child with res-
piratory obstruction and cor pulmonale. J. Pediatr. 67:
192–197.
84. Sofer, S., E. Weinhouse, A. Tal, et al. 1988. Cor pul-
monale due to adenoidal or tonsillar hypertrophy or
both in children. Noninvasive diagnosis and follow-up.
Chest 93: 119–122.
85. Marcus, C.L., S. Curtis, C.B. Koerner, et al. 1996. Evalu-
ation of pulmonary function and polysomnography in
obese children and adolescents. Pediatr. Pulmonol. 21:
176–183.
86. Kalra, M., T. Inge, V. Garcia, et al. 2005. Obstructive
sleep apnea in extremely overweight adolescents un-
dergoing bariatric surgery. Obes. Res. 13: 1175–1179.
87. Marcus, C.L. & C.L. Marcus. 2002. Total energy
expenditure in children with obstructive sleep ap-
noea syndrome [comment]. Eur. Respir. J. 19: 1215–
1216.
88. Grigg-Damberger, M., D. Gozal, C.L. Marcus, et al.
2007. The visual scoring of sleep and arousal in infants
and children. J. Clin. Sleep. Med. 3: 201–240.
89. Rosen, C.L., L. D’Andrea & G.G. Haddad. 1992. Adult
criteria for obstructive sleep apnea do not identify chil-
dren with serious obstruction. Am. Rev. Respir. Dis.
146(5 Pt 1): 1231–1234.
90. Zaremba, E.K., M.E. Barkey, C. Mesa, et al. 2005. Mak-
ing polysomnography more “child friendly:” a family-
centered care approach. J. Clin. Sleep. Med. 1: 189–198.
91. Mangat, D., W.C. Orr & R.O. Smith. 1977. Sleep ap-
nea, hypersomnolence, and upper airway obstruction
secondary to adenotonsillar enlargement. Arch. Oto-
laryngol. 103: 383–386.
92. Section on Pediatric Pulmonology SoOSASAAoP. 2002.
Clinical practice guideline: diagnosis and management
of childhood obstructive sleep apnea syndrome [see
comment]. Pediatrics 109: 704–712.
93. Brietzke, S.E. & D. Gallagher. 2006. The effectiveness of
tonsillectomy and adenoidectomy in the treatment of
pediatric obstructive sleep apnea/hypopnea syndrome:
a meta-analysis. Otolaryngol. Head Neck Surg. 134: 979–
984.
94. Tauman, R., T.E. Gulliver, J. Krishna, et al. 2006. Persis-
tence of obstructive sleep apnea syndrome in children
after adenotonsillectomy. J. Pediatr. 149: 803–808.
95. Guilleminault, C., Y.S. Huang, C. Glamann, et al. 2007.
Adenotonsillectomy and obstructive sleep apnea in
children: a prospective survey. Otolaryngol. Head Neck
Surg. 136: 169–175.
96. Guilleminault, C., M. Partinen, J.P. Praud, et al. 1989.
Morphometric facial changes and obstructive sleep ap-
nea in adolescents. J. Pediatr. 114: 997–999.
97. Amin, R., L. Anthony, V. Somers, et al. 2008. Growth
velocity predicts recurrence of sleep-disordered breath-
ing 1 year after adenotonsillectomy. Am. J. Respir. Crit.
Care Med. 177: 654–659.
98. O’Donnell, A.R., C.L. Bjornson, S.G. Bohn & V.G. Kirk.
2006. Compliance rates in children using noninvasive
Ann. N.Y. Acad. Sci. 1184 (2010) 1–14 c© 2009 New York Academy of Sciences. 13
Sleep disorders in children Hoban
continuous positive airway pressure. Sleep 29: 651–
658.
99. Massa, F., S. Gonsalez, A. Laverty, et al. 2002. The use
of nasal continuous positive airway pressure to treat
obstructive sleep apnoea. Arch. Dis. Child. 87: 438–
443.
100. Kheirandish-Gozal, L., D. Gozal, L. Kheirandish-Gozal
& D. Gozal. 2008. Intranasal budesonide treatment for
children with mild obstructive sleep apnea syndrome.
Pediatrics 122: e149–e155.
101. Mansfield, L.E., G. Diaz, C.R. Posey & J. Flores-Neder.
2004. Sleep disordered breathing and daytime quality
of life in children with allergic rhinitis during treat-
ment with intranasal budesonide. Ann. Allergy Asthma
Immunol. 92: 240–244.
102. Kotagal, S. 1996. Narcolepsy in children. Semin. Pediatr.
Neurol. 3: 36–43.
103. Smit, L.S., G.J. Lammers & C.E. Catsman-Berrevoets.
2006. Cataplexy leading to the diagnosis of Niemann-
Pick disease type C. Pediatr. Neurol. 35: 82–84.
104. Tobias, E.S., J.L. Tolmie & J.B. Stephenson. 2002. Cat-
aplexy in the Prader-Willi syndrome. Arch. Dis. Child.
87: 170.
105. Vendrame, M., N. Havaligi, C. Matadeen-Ali, et al.
2008. Narcolepsy in children: a single-center clinical
experience. Pediatr. Neurol. 38: 314–320.
106. Morgenthaler, T.I., V.K. Kapur, T. Brown, et al. 2007.
Practice parameters for the treatment of narcolepsy and
other hypersomnias of central origin. Sleep 30: 1705–
1711.
107. Wise, M.S., D.L. Arand, R.R. Auger, et al. 2007. Treat-
ment of narcolepsy and other hypersomnias of central
origin. Sleep 30: 1712–1727.
108. Murali, H. & S. Kotagal. 2006. Off-label treatment of se-
vere childhood narcolepsy-cataplexy with sodium oxy-
bate. Sleep 29: 1025–1029.
109. Arnulf, I., L. Lin, N. Gadoth, et al. 2008. Kleine-Levin
syndrome: a systematic study of 108 patients. Ann. Neu-
rol. 63: 482–493.
110. Arnulf, I., M. Lecendreux, P. Franco & Y. Dauvilliers.
2008. [Kleine-Levin syndrome: state of the art]. Rev.
Neurol. (Paris) 164: 658–668.
111. Portilla, P., E. Durand, A. Chalvon, et al. 2002. [SPECT-
identified hypoperfusion of the left temporomesial
structures in a Kleine-Levin syndrome]. Rev. Neurol.
(Paris) 158(5 Pt 1): 593–595.
14 Ann. N.Y. Acad. Sci. 1184 (2010) 1–14 c© 2009 New York Academy of Sciences.
